Medicine Prices: Secrecy Of R&D Costs Remains Issue In Near-Final World Health Assembly Resolution 26/05/2019 Elaine Ruth Fletcher The latest working draft World Health Assembly resolution calling for game-changing public disclosure of the prices paid for medicines, vaccines and other health products by countries and health systems shows a broad coalition of countries from Europe, Latin America, Africa and Asia forming around the compromise draft. The draft, obtained Sunday by Health Policy Watch, […] Continue reading -> Medicine Prices – Delegates Near Agreement On Softer Resolution For Disclosure 26/05/2019 Elaine Ruth Fletcher After a grueling 34 hours of nearly non-stop negotiations, World Health Assembly delegates appeared to be close to a final agreement Saturday evening on a resolution supporting more systematic disclosure of prices for medicines purchased and sold on national and global markets; a “drafting group” is expected to reconvene Monday morning to put the finishing […] Continue reading -> Six International Organisations Pledge Collaboration On Local Production Of Medicines 24/05/2019 Catherine Saez While delegates remained bogged down today in negotiations to find consensus on a resolution to increase transparency of pharma prices, five United Nations agencies and the Global Fund to Fight AIDS, Tuberculosis and Malaria forged a brand new collaboration to promote local production of medicines. The World Health Organization, the UN Industrial Development Organization (UNIDO), […] Continue reading -> Little Progress Over Price Transparency Resolution; Negotiators Behind Closed Doors 24/05/2019 Catherine Saez Secrecy was the watchword Friday as countries huddled together behind closed doors trying to reach agreement on a WHA resolution that would shed more sunshine on the real prices of medicines in national and global pharmaceutical markets. Image Credits: Max Pixel, Catherine Saez. Continue reading -> Price Transparency In Medicines Markets – Scrutinizing Evidence Behind The Claims 24/05/2019 Editorial team As the debate over a draft resolution supporting greater price transparency for medicines in national and global markets intensifies, with closed-door consultations among countries at the 72nd World Health Assembly continuing late into the night, Health Policy Watch continues to feature diverse “Inside Views” on this charged issue. Here, Suerie Moon, MPA PhD, faculty member […] Continue reading -> Behind The Headlines: How Can Industry Contribute To Cancer Care As Part Of Universal Health Coverage? 24/05/2019 Elaine Ruth Fletcher From preventive screening to the quality of nursing care and the structure of national insurance systems, patients face multiple barriers to cancer prevention, treatment and care, said a high-level panel of experts at a side event on the margins of this week’s World Health Assembly (20-28 May). Image Credits: UnternehmerTUM/@birdyfoto.de. Continue reading -> Future Of Drug Pricing Resolution Hangs In Balance At World Health Assembly 23/05/2019 Catherine Saez The fate of a potentially game-changing World Health Assembly resolution that would support greater national and global transparency in drug pricing remained in the balance today as the country co-sponsors tabled a resolution riddled with comments and caveats, and a “drafting group” was urgently formed to huddle on ways to move forward on a compromise […] Continue reading -> How transparency of the costs of clinical trials will improve policy making 23/05/2019 Editorial team [Re-posted from Knowledge Ecology International.] By James Love, Director of Knowledge Ecology International (KEI) – 22 May 2019 Perhaps the toughest issue in the 72nd World Health Assembly negotiations on a WHO transparency resolution concerns the proposal to require public reporting of the costs of each clinical trial undertaken for development of drugs, vaccines, cell- […] Continue reading -> Collaboration & Science To Fight Epidemics, A Long Road Still Ahead – Speakers Say On the Margins Of WHA 21/05/2019 Catherine Saez The Ebola epidemic in the Democratic Republic of the Congo is enduring despite efforts deployed and progress achieved, mainly because of the difficulty to reach communities. The complexity of the response to this epidemic prompts actors to rethink their strategy, as explained by the head of Wellcome Trust yesterday on the side of the World […] Continue reading -> Fight The Fakes Panel Spotlights Digital Innovation To Combat Dangerous Fake Drugs 21/05/2019 Divya Schlesinger Raised in the digital era and fluent in the innovations of technology, youth are the driving force behind many advancements in global health, even spearheading a campaign against falsified and substandard medicines. Fight the Fakes, a campaign to raise public awareness about the dangers of falsified medicines, joined forces with the 72nd World Health Assembly […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Medicine Prices – Delegates Near Agreement On Softer Resolution For Disclosure 26/05/2019 Elaine Ruth Fletcher After a grueling 34 hours of nearly non-stop negotiations, World Health Assembly delegates appeared to be close to a final agreement Saturday evening on a resolution supporting more systematic disclosure of prices for medicines purchased and sold on national and global markets; a “drafting group” is expected to reconvene Monday morning to put the finishing […] Continue reading -> Six International Organisations Pledge Collaboration On Local Production Of Medicines 24/05/2019 Catherine Saez While delegates remained bogged down today in negotiations to find consensus on a resolution to increase transparency of pharma prices, five United Nations agencies and the Global Fund to Fight AIDS, Tuberculosis and Malaria forged a brand new collaboration to promote local production of medicines. The World Health Organization, the UN Industrial Development Organization (UNIDO), […] Continue reading -> Little Progress Over Price Transparency Resolution; Negotiators Behind Closed Doors 24/05/2019 Catherine Saez Secrecy was the watchword Friday as countries huddled together behind closed doors trying to reach agreement on a WHA resolution that would shed more sunshine on the real prices of medicines in national and global pharmaceutical markets. Image Credits: Max Pixel, Catherine Saez. Continue reading -> Price Transparency In Medicines Markets – Scrutinizing Evidence Behind The Claims 24/05/2019 Editorial team As the debate over a draft resolution supporting greater price transparency for medicines in national and global markets intensifies, with closed-door consultations among countries at the 72nd World Health Assembly continuing late into the night, Health Policy Watch continues to feature diverse “Inside Views” on this charged issue. Here, Suerie Moon, MPA PhD, faculty member […] Continue reading -> Behind The Headlines: How Can Industry Contribute To Cancer Care As Part Of Universal Health Coverage? 24/05/2019 Elaine Ruth Fletcher From preventive screening to the quality of nursing care and the structure of national insurance systems, patients face multiple barriers to cancer prevention, treatment and care, said a high-level panel of experts at a side event on the margins of this week’s World Health Assembly (20-28 May). Image Credits: UnternehmerTUM/@birdyfoto.de. Continue reading -> Future Of Drug Pricing Resolution Hangs In Balance At World Health Assembly 23/05/2019 Catherine Saez The fate of a potentially game-changing World Health Assembly resolution that would support greater national and global transparency in drug pricing remained in the balance today as the country co-sponsors tabled a resolution riddled with comments and caveats, and a “drafting group” was urgently formed to huddle on ways to move forward on a compromise […] Continue reading -> How transparency of the costs of clinical trials will improve policy making 23/05/2019 Editorial team [Re-posted from Knowledge Ecology International.] By James Love, Director of Knowledge Ecology International (KEI) – 22 May 2019 Perhaps the toughest issue in the 72nd World Health Assembly negotiations on a WHO transparency resolution concerns the proposal to require public reporting of the costs of each clinical trial undertaken for development of drugs, vaccines, cell- […] Continue reading -> Collaboration & Science To Fight Epidemics, A Long Road Still Ahead – Speakers Say On the Margins Of WHA 21/05/2019 Catherine Saez The Ebola epidemic in the Democratic Republic of the Congo is enduring despite efforts deployed and progress achieved, mainly because of the difficulty to reach communities. The complexity of the response to this epidemic prompts actors to rethink their strategy, as explained by the head of Wellcome Trust yesterday on the side of the World […] Continue reading -> Fight The Fakes Panel Spotlights Digital Innovation To Combat Dangerous Fake Drugs 21/05/2019 Divya Schlesinger Raised in the digital era and fluent in the innovations of technology, youth are the driving force behind many advancements in global health, even spearheading a campaign against falsified and substandard medicines. Fight the Fakes, a campaign to raise public awareness about the dangers of falsified medicines, joined forces with the 72nd World Health Assembly […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Six International Organisations Pledge Collaboration On Local Production Of Medicines 24/05/2019 Catherine Saez While delegates remained bogged down today in negotiations to find consensus on a resolution to increase transparency of pharma prices, five United Nations agencies and the Global Fund to Fight AIDS, Tuberculosis and Malaria forged a brand new collaboration to promote local production of medicines. The World Health Organization, the UN Industrial Development Organization (UNIDO), […] Continue reading -> Little Progress Over Price Transparency Resolution; Negotiators Behind Closed Doors 24/05/2019 Catherine Saez Secrecy was the watchword Friday as countries huddled together behind closed doors trying to reach agreement on a WHA resolution that would shed more sunshine on the real prices of medicines in national and global pharmaceutical markets. Image Credits: Max Pixel, Catherine Saez. Continue reading -> Price Transparency In Medicines Markets – Scrutinizing Evidence Behind The Claims 24/05/2019 Editorial team As the debate over a draft resolution supporting greater price transparency for medicines in national and global markets intensifies, with closed-door consultations among countries at the 72nd World Health Assembly continuing late into the night, Health Policy Watch continues to feature diverse “Inside Views” on this charged issue. Here, Suerie Moon, MPA PhD, faculty member […] Continue reading -> Behind The Headlines: How Can Industry Contribute To Cancer Care As Part Of Universal Health Coverage? 24/05/2019 Elaine Ruth Fletcher From preventive screening to the quality of nursing care and the structure of national insurance systems, patients face multiple barriers to cancer prevention, treatment and care, said a high-level panel of experts at a side event on the margins of this week’s World Health Assembly (20-28 May). Image Credits: UnternehmerTUM/@birdyfoto.de. Continue reading -> Future Of Drug Pricing Resolution Hangs In Balance At World Health Assembly 23/05/2019 Catherine Saez The fate of a potentially game-changing World Health Assembly resolution that would support greater national and global transparency in drug pricing remained in the balance today as the country co-sponsors tabled a resolution riddled with comments and caveats, and a “drafting group” was urgently formed to huddle on ways to move forward on a compromise […] Continue reading -> How transparency of the costs of clinical trials will improve policy making 23/05/2019 Editorial team [Re-posted from Knowledge Ecology International.] By James Love, Director of Knowledge Ecology International (KEI) – 22 May 2019 Perhaps the toughest issue in the 72nd World Health Assembly negotiations on a WHO transparency resolution concerns the proposal to require public reporting of the costs of each clinical trial undertaken for development of drugs, vaccines, cell- […] Continue reading -> Collaboration & Science To Fight Epidemics, A Long Road Still Ahead – Speakers Say On the Margins Of WHA 21/05/2019 Catherine Saez The Ebola epidemic in the Democratic Republic of the Congo is enduring despite efforts deployed and progress achieved, mainly because of the difficulty to reach communities. The complexity of the response to this epidemic prompts actors to rethink their strategy, as explained by the head of Wellcome Trust yesterday on the side of the World […] Continue reading -> Fight The Fakes Panel Spotlights Digital Innovation To Combat Dangerous Fake Drugs 21/05/2019 Divya Schlesinger Raised in the digital era and fluent in the innovations of technology, youth are the driving force behind many advancements in global health, even spearheading a campaign against falsified and substandard medicines. Fight the Fakes, a campaign to raise public awareness about the dangers of falsified medicines, joined forces with the 72nd World Health Assembly […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Little Progress Over Price Transparency Resolution; Negotiators Behind Closed Doors 24/05/2019 Catherine Saez Secrecy was the watchword Friday as countries huddled together behind closed doors trying to reach agreement on a WHA resolution that would shed more sunshine on the real prices of medicines in national and global pharmaceutical markets. Image Credits: Max Pixel, Catherine Saez. Continue reading -> Price Transparency In Medicines Markets – Scrutinizing Evidence Behind The Claims 24/05/2019 Editorial team As the debate over a draft resolution supporting greater price transparency for medicines in national and global markets intensifies, with closed-door consultations among countries at the 72nd World Health Assembly continuing late into the night, Health Policy Watch continues to feature diverse “Inside Views” on this charged issue. Here, Suerie Moon, MPA PhD, faculty member […] Continue reading -> Behind The Headlines: How Can Industry Contribute To Cancer Care As Part Of Universal Health Coverage? 24/05/2019 Elaine Ruth Fletcher From preventive screening to the quality of nursing care and the structure of national insurance systems, patients face multiple barriers to cancer prevention, treatment and care, said a high-level panel of experts at a side event on the margins of this week’s World Health Assembly (20-28 May). Image Credits: UnternehmerTUM/@birdyfoto.de. Continue reading -> Future Of Drug Pricing Resolution Hangs In Balance At World Health Assembly 23/05/2019 Catherine Saez The fate of a potentially game-changing World Health Assembly resolution that would support greater national and global transparency in drug pricing remained in the balance today as the country co-sponsors tabled a resolution riddled with comments and caveats, and a “drafting group” was urgently formed to huddle on ways to move forward on a compromise […] Continue reading -> How transparency of the costs of clinical trials will improve policy making 23/05/2019 Editorial team [Re-posted from Knowledge Ecology International.] By James Love, Director of Knowledge Ecology International (KEI) – 22 May 2019 Perhaps the toughest issue in the 72nd World Health Assembly negotiations on a WHO transparency resolution concerns the proposal to require public reporting of the costs of each clinical trial undertaken for development of drugs, vaccines, cell- […] Continue reading -> Collaboration & Science To Fight Epidemics, A Long Road Still Ahead – Speakers Say On the Margins Of WHA 21/05/2019 Catherine Saez The Ebola epidemic in the Democratic Republic of the Congo is enduring despite efforts deployed and progress achieved, mainly because of the difficulty to reach communities. The complexity of the response to this epidemic prompts actors to rethink their strategy, as explained by the head of Wellcome Trust yesterday on the side of the World […] Continue reading -> Fight The Fakes Panel Spotlights Digital Innovation To Combat Dangerous Fake Drugs 21/05/2019 Divya Schlesinger Raised in the digital era and fluent in the innovations of technology, youth are the driving force behind many advancements in global health, even spearheading a campaign against falsified and substandard medicines. Fight the Fakes, a campaign to raise public awareness about the dangers of falsified medicines, joined forces with the 72nd World Health Assembly […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Price Transparency In Medicines Markets – Scrutinizing Evidence Behind The Claims 24/05/2019 Editorial team As the debate over a draft resolution supporting greater price transparency for medicines in national and global markets intensifies, with closed-door consultations among countries at the 72nd World Health Assembly continuing late into the night, Health Policy Watch continues to feature diverse “Inside Views” on this charged issue. Here, Suerie Moon, MPA PhD, faculty member […] Continue reading -> Behind The Headlines: How Can Industry Contribute To Cancer Care As Part Of Universal Health Coverage? 24/05/2019 Elaine Ruth Fletcher From preventive screening to the quality of nursing care and the structure of national insurance systems, patients face multiple barriers to cancer prevention, treatment and care, said a high-level panel of experts at a side event on the margins of this week’s World Health Assembly (20-28 May). Image Credits: UnternehmerTUM/@birdyfoto.de. Continue reading -> Future Of Drug Pricing Resolution Hangs In Balance At World Health Assembly 23/05/2019 Catherine Saez The fate of a potentially game-changing World Health Assembly resolution that would support greater national and global transparency in drug pricing remained in the balance today as the country co-sponsors tabled a resolution riddled with comments and caveats, and a “drafting group” was urgently formed to huddle on ways to move forward on a compromise […] Continue reading -> How transparency of the costs of clinical trials will improve policy making 23/05/2019 Editorial team [Re-posted from Knowledge Ecology International.] By James Love, Director of Knowledge Ecology International (KEI) – 22 May 2019 Perhaps the toughest issue in the 72nd World Health Assembly negotiations on a WHO transparency resolution concerns the proposal to require public reporting of the costs of each clinical trial undertaken for development of drugs, vaccines, cell- […] Continue reading -> Collaboration & Science To Fight Epidemics, A Long Road Still Ahead – Speakers Say On the Margins Of WHA 21/05/2019 Catherine Saez The Ebola epidemic in the Democratic Republic of the Congo is enduring despite efforts deployed and progress achieved, mainly because of the difficulty to reach communities. The complexity of the response to this epidemic prompts actors to rethink their strategy, as explained by the head of Wellcome Trust yesterday on the side of the World […] Continue reading -> Fight The Fakes Panel Spotlights Digital Innovation To Combat Dangerous Fake Drugs 21/05/2019 Divya Schlesinger Raised in the digital era and fluent in the innovations of technology, youth are the driving force behind many advancements in global health, even spearheading a campaign against falsified and substandard medicines. Fight the Fakes, a campaign to raise public awareness about the dangers of falsified medicines, joined forces with the 72nd World Health Assembly […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Behind The Headlines: How Can Industry Contribute To Cancer Care As Part Of Universal Health Coverage? 24/05/2019 Elaine Ruth Fletcher From preventive screening to the quality of nursing care and the structure of national insurance systems, patients face multiple barriers to cancer prevention, treatment and care, said a high-level panel of experts at a side event on the margins of this week’s World Health Assembly (20-28 May). Image Credits: UnternehmerTUM/@birdyfoto.de. Continue reading -> Future Of Drug Pricing Resolution Hangs In Balance At World Health Assembly 23/05/2019 Catherine Saez The fate of a potentially game-changing World Health Assembly resolution that would support greater national and global transparency in drug pricing remained in the balance today as the country co-sponsors tabled a resolution riddled with comments and caveats, and a “drafting group” was urgently formed to huddle on ways to move forward on a compromise […] Continue reading -> How transparency of the costs of clinical trials will improve policy making 23/05/2019 Editorial team [Re-posted from Knowledge Ecology International.] By James Love, Director of Knowledge Ecology International (KEI) – 22 May 2019 Perhaps the toughest issue in the 72nd World Health Assembly negotiations on a WHO transparency resolution concerns the proposal to require public reporting of the costs of each clinical trial undertaken for development of drugs, vaccines, cell- […] Continue reading -> Collaboration & Science To Fight Epidemics, A Long Road Still Ahead – Speakers Say On the Margins Of WHA 21/05/2019 Catherine Saez The Ebola epidemic in the Democratic Republic of the Congo is enduring despite efforts deployed and progress achieved, mainly because of the difficulty to reach communities. The complexity of the response to this epidemic prompts actors to rethink their strategy, as explained by the head of Wellcome Trust yesterday on the side of the World […] Continue reading -> Fight The Fakes Panel Spotlights Digital Innovation To Combat Dangerous Fake Drugs 21/05/2019 Divya Schlesinger Raised in the digital era and fluent in the innovations of technology, youth are the driving force behind many advancements in global health, even spearheading a campaign against falsified and substandard medicines. Fight the Fakes, a campaign to raise public awareness about the dangers of falsified medicines, joined forces with the 72nd World Health Assembly […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Future Of Drug Pricing Resolution Hangs In Balance At World Health Assembly 23/05/2019 Catherine Saez The fate of a potentially game-changing World Health Assembly resolution that would support greater national and global transparency in drug pricing remained in the balance today as the country co-sponsors tabled a resolution riddled with comments and caveats, and a “drafting group” was urgently formed to huddle on ways to move forward on a compromise […] Continue reading -> How transparency of the costs of clinical trials will improve policy making 23/05/2019 Editorial team [Re-posted from Knowledge Ecology International.] By James Love, Director of Knowledge Ecology International (KEI) – 22 May 2019 Perhaps the toughest issue in the 72nd World Health Assembly negotiations on a WHO transparency resolution concerns the proposal to require public reporting of the costs of each clinical trial undertaken for development of drugs, vaccines, cell- […] Continue reading -> Collaboration & Science To Fight Epidemics, A Long Road Still Ahead – Speakers Say On the Margins Of WHA 21/05/2019 Catherine Saez The Ebola epidemic in the Democratic Republic of the Congo is enduring despite efforts deployed and progress achieved, mainly because of the difficulty to reach communities. The complexity of the response to this epidemic prompts actors to rethink their strategy, as explained by the head of Wellcome Trust yesterday on the side of the World […] Continue reading -> Fight The Fakes Panel Spotlights Digital Innovation To Combat Dangerous Fake Drugs 21/05/2019 Divya Schlesinger Raised in the digital era and fluent in the innovations of technology, youth are the driving force behind many advancements in global health, even spearheading a campaign against falsified and substandard medicines. Fight the Fakes, a campaign to raise public awareness about the dangers of falsified medicines, joined forces with the 72nd World Health Assembly […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
How transparency of the costs of clinical trials will improve policy making 23/05/2019 Editorial team [Re-posted from Knowledge Ecology International.] By James Love, Director of Knowledge Ecology International (KEI) – 22 May 2019 Perhaps the toughest issue in the 72nd World Health Assembly negotiations on a WHO transparency resolution concerns the proposal to require public reporting of the costs of each clinical trial undertaken for development of drugs, vaccines, cell- […] Continue reading -> Collaboration & Science To Fight Epidemics, A Long Road Still Ahead – Speakers Say On the Margins Of WHA 21/05/2019 Catherine Saez The Ebola epidemic in the Democratic Republic of the Congo is enduring despite efforts deployed and progress achieved, mainly because of the difficulty to reach communities. The complexity of the response to this epidemic prompts actors to rethink their strategy, as explained by the head of Wellcome Trust yesterday on the side of the World […] Continue reading -> Fight The Fakes Panel Spotlights Digital Innovation To Combat Dangerous Fake Drugs 21/05/2019 Divya Schlesinger Raised in the digital era and fluent in the innovations of technology, youth are the driving force behind many advancements in global health, even spearheading a campaign against falsified and substandard medicines. Fight the Fakes, a campaign to raise public awareness about the dangers of falsified medicines, joined forces with the 72nd World Health Assembly […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Collaboration & Science To Fight Epidemics, A Long Road Still Ahead – Speakers Say On the Margins Of WHA 21/05/2019 Catherine Saez The Ebola epidemic in the Democratic Republic of the Congo is enduring despite efforts deployed and progress achieved, mainly because of the difficulty to reach communities. The complexity of the response to this epidemic prompts actors to rethink their strategy, as explained by the head of Wellcome Trust yesterday on the side of the World […] Continue reading -> Fight The Fakes Panel Spotlights Digital Innovation To Combat Dangerous Fake Drugs 21/05/2019 Divya Schlesinger Raised in the digital era and fluent in the innovations of technology, youth are the driving force behind many advancements in global health, even spearheading a campaign against falsified and substandard medicines. Fight the Fakes, a campaign to raise public awareness about the dangers of falsified medicines, joined forces with the 72nd World Health Assembly […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Fight The Fakes Panel Spotlights Digital Innovation To Combat Dangerous Fake Drugs 21/05/2019 Divya Schlesinger Raised in the digital era and fluent in the innovations of technology, youth are the driving force behind many advancements in global health, even spearheading a campaign against falsified and substandard medicines. Fight the Fakes, a campaign to raise public awareness about the dangers of falsified medicines, joined forces with the 72nd World Health Assembly […] Continue reading -> Posts navigation Older postsNewer posts